Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21668713 | 1.00 | PRKDC (0.34) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL21668818 | 0.99 | PRKDC (0.35) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL21669076 | 0.99 | PRKDC (0.34) | PRKDCTSHRALDH1A1MAPTALOX5 | |
| SCHEMBL24963169 | 0.98 | PRKDC (0.33) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL21668716 | 0.98 | PRKDC (0.33) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL21668978 | 0.98 | PRKDC (0.33) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL21668977 | 0.98 | PRKDC (0.36) | PRKDCTSHRALDH1A1HTR1ADRD2 | |
| SCHEMBL21668711 | 0.98 | PRKDC (0.35) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL25494345 | 0.98 | PRKDC (0.35) | PRKDCTSHRMMP12MMP13ALDH1A1 | |
| SCHEMBL25926470 | 0.98 | PRKDC (0.35) | PRKDCTSHRMMP12MMP13ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | PRKDC 3767/4885TSHR 4694/4885MMP12 4150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.